Press release
At 8.9% of CAGR, Immunotherapy Drugs Market Size to Cross US$ 327.8 Billion by 2028 - IMARC Group
Immunotherapy drugs represent specialized medications that are used for treating melanoma, lymphoma, sarcoma, and lung, bladder, kidney, and breast cancer. They usually target specific cells of the immune system and boost energy levels. In line with this, immunotherapy drugs stimulate the natural defenses of the body and help in fighting against allergies and infections caused by viruses and bacteria. They also assist in preventing the growth of cancer cells by triggering an immunological response that generates antibodies. Furthermore, immunotherapy drugs are effective in minimizing the complications of tumors and other chronic disorders. Consequently, they are gaining extensive traction across the globe.
We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Request a free sample brochure: https://www.imarcgroup.com/immunotherapy-drugs-market/requestsample
Immunotherapy Drugs Market Trends and Drivers:
The expanding geriatric population and the elevating prevalence of tumor and target diseases are primarily driving the immunotherapy drugs market. Additionally, the rising occurrence of numerous genetic and lifestyle disorders and the increasing awareness among healthcare professionals and individuals towards the benefits of early diagnosis and treatment of cancer are further catalyzing the market growth. Besides this, the escalating demand for monoclonal antibodies and biosimilar drugs and the growing number of hospitals, pharmacies, and research laboratories are acting as significant growth-inducing factors. Moreover, key market players are focusing on strategic collaborations and new product developments to expand their product portfolio and gain a competitive edge, which is also positively influencing the global market. Apart from this, extensive investments in R&D activities by leading pharmaceutical and biotechnology companies to enhance the formulation of these medications are expected to fuel the immunotherapy drugs market over the forecasted period.
Inquire Before Buying: https://www.imarcgroup.com/request?type=report&id=6639&flag=F
Immunotherapy Drugs Market Report Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
• AstraZeneca plc
• Bayer AG
• Boehringer Ingelheim International GmbH
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG
• GSK plc, Merck & Co. Inc.
• Pfizer Inc. and Sanofi S.A.
The report has been segmented the market into following categories:
Breakup by Type:
• Monoclonal Antibodies
• Vaccines
• Interferons Alpha and Beta
• Interleukins
Breakup by Therapy Area:
• Cancer
• Autoimmune and Inflammatory Diseases
• Infectious Diseases
• Others
Breakup by End User:
• Hospitals
• Clinics
• Others
Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/immunotherapy-drugs-market
Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa
Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Also Read:
• https://www.marketwatch.com/press-release/atopic-dermatitis-market-size-2023-global-trends-industry-share-top-companies-and-report-by-2033-2023-01-10
• https://www.marketwatch.com/press-release/urinary-retention-market-size-2023-trends-industry-share-top-companies-and-report-by-2033-2023-01-10
• https://www.marketwatch.com/press-release/specialty-adhesives-market-size-2023-global-trends-industry-share-top-companies-and-report-by-2028-2023-01-10
• https://www.marketwatch.com/press-release/ultra-mobile-device-market-report-2023-global-size-industry-share-trends-top-companies-and-forecast-by-2028-2023-01-10
• https://www.marketwatch.com/press-release/automotive-thermoelectric-generator-market-report-2023-global-size-industry-share-trends-top-companies-and-forecast-by-2028-2023-01-10
• https://www.marketwatch.com/press-release/high-throughput-satellite-market-report-2023-global-size-industry-share-trends-top-companies-and-forecast-by-2028-2023-01-10
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release At 8.9% of CAGR, Immunotherapy Drugs Market Size to Cross US$ 327.8 Billion by 2028 - IMARC Group here
News-ID: 2883926 • Views: …
More Releases from IMARC Group
Supercapacitor Market Size to Reach $31.07B by 2033: Trends & Opportunities
Market Overview:
The supercapacitor market is experiencing rapid growth, driven by electrification of automotive systems, renewable energy and grid stabilization, and expansion of industrial automation and robotics. According to IMARC Group's latest research publication, "Supercapacitor Market Size, Share, Trends and Forecast by Product Type, Module Type, Material Type, End Use Industry, and Region, 2025-2033", the global supercapacitor market size was valued at USD 6.41 Billion in 2024. Looking forward, IMARC Group…
Bicycle Market Size to Surpass $102.05B by 2033: Growth & Insights
Market Overview:
The bicycle market is experiencing rapid growth, driven by global expansion of cycling infrastructure, rising health consciousness and preventative wellness, and technological advancements in e-bike propulsion. According to IMARC Group's latest research publication, "Bicycle Market Size, Share, Trends and Forecast by Type, Technology, Price, Distribution Channel, End User, and Region, 2025-2033", The global bicycle market size was valued at USD 67.42 Billion in 2024. Looking forward, IMARC Group estimates…
Baby Food and Infant Formula Market to Reach USD 84.06 Billion by 2033, Growing …
Market Overview:
The Baby Food and Infant Formula Market is experiencing steady expansion, driven by Increasing Awareness of Nutritional Needs for Infants, Rising Number of Working Women, and Technological Advancements and Product Innovation. According to IMARC Group's latest research publication, "Baby Food and Infant Formula Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global baby food and infant formula market size reached USD 53.73 Billion in 2024.…
Breakfast Cereals Market to Reach USD 149.07 Billion by 2033, Growing at a CAGR …
Market Overview:
The Breakfast Cereals Market is experiencing rapid growth, driven by Health and Wellness Awareness, Busy Lifestyles and On-the-Go Demand and Rising Disposable Incomes and Global Market Expansion . According to IMARC Group's latest research publication, "Breakfast Cereals Market : Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2025-2033", The global breakfast cereals market size was valued at USD 108.89 Billion in 2024. Looking forward, IMARC Group estimates…
More Releases for Immunotherapy
Immunotherapy Drugs Market
Immunotherapy Drugs Market Size reached US$ 288.02 Billion in 2024 and is expected to reach US$ 872.64 Billion by 2033, growing at a CAGR of 13.2% during the forecast period 2025-2033.
The Immunotherapy Drugs Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead…
Anti TIGIT Antibodies Revolutionizing Immunotherapy
Anti-TIGIT antibodies are at the forefront of a revolution in immunotherapy, representing a new class of immune checkpoint inhibitors that have the potential to transform the treatment landscape for cancer. Immunotherapy, which harnesses the body's immune system to fight cancer, has already made significant strides with the introduction of PD-1, PD-L1, and CTLA-4 inhibitors. However, the discovery and development of anti-TIGIT antibodies add a new dimension to this field, offering…
Allergy Immunotherapy Market Combating the Rising Tide: The Allergy Immunotherap …
Allergy Immunotherapy Market is to reach over USD 4.01 billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Allergy Immunotherapy Market Size, Share & Trends Analysis Report By Treatment Type (SCIT, SLIT), By Allergy Type (Allergic Rhinitis, Asthma), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), Region, Market Outlook And Industry Analysis…
Allergy Immunotherapy Market - Empowering Resilience, Defying Allergies: Advanci …
Newark, New Castle, USA - new report, titled Allergy Immunotherapy Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Allergy Immunotherapy market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Allergy Immunotherapy market. The report offers an overview of the market, which…
Cancer Immunotherapy Market Cancer Immunotherapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Immunotherapy: Mending Cancer Regimens
1.1 Preface to Cancer Immunotherapy
1.2 Evolution of Cancer Immunotherapy
2. Categorization of Cancer Immunotherapy
2.1 Specific Cancer Immunotherapy
2.1.1 Cancer Vaccines
2.1.2 Monoclonal Antibodies
2.2 Non-Specific Cancer Immunotherapy
2.2.1 Adoptive Cell Transfer Immunotherapy
2.2.2 Immune Checkpoint Inhibitors
3. Fundamentals…
Global Cancer Immunotherapy Market & Cancer Immunotherapy Clinical Trials Outloo …
Pharmaceutical companies are actively engaged in research and development of cancer immunotherapies because of large unmet medical necessities. Investigators are trying to come forth with innovative cancer immunotherapeutic products having high safety and efficacy profiles which are not offered by conventional therapeutics.
Higher investments in research and development segment could significantly increase the drug discovery rates which will alleviate the medical condition of cancer patients. Simultaneously, technological advancements are being…
